Comorbidity predicts poor prognosis in nasopharyngeal carcinoma: Development and validation of a predictive score model

Radiotherapy and Oncology

Volumn 114, Issue 2, 2015, Pages 249-256

  Guo, Rui ^a   Chen, Xiao Zhong ^b   Chen, Lei ^a   Jiang, Feng ^b   Tang, Ling Long ^a   Mao, Yan Ping ^a   Zhou, Guan Qun ^a   Li, Wen Fei ^a   Liu, Li Zhi ^a   Tian, Li ^a   Lin, Ai Hua ^c   Ma, Jun ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b ZHEJIANG CANCER HOSPITAL   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Comorbidity; Multi cancer centre; Nasopharyngeal carcinoma; Prognosis; Survival

Indexed keywords

CISPLATIN; FLUOROURACIL; TAXOID;

ADULT; ADULT COMORBIDITY EVALUATION 27 SCORE; ARTICLE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CARDIOVASCULAR DISEASE; COMORBIDITY; COMORBIDITY ASSESSMENT; COMPUTER ASSISTED RADIOTHERAPY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DISTANT METASTASIS; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCORING SYSTEM; SUBSTANCE ABUSE; AGED; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PATHOLOGY; PROGNOSIS; REPRODUCIBILITY; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGED; COMORBIDITY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 84926173690     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.12.002     Document Type: Article

References (36)

1. A. Jemal, F. Bray, and M.M. Center Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. W.I. Wei, and J.S.T. Sham Nasopharyngeal carcinoma Lancet 365 2005 2041 2054
3. R.P. Takes, A. Rinaldo, and C.E. Silver Future of the TNM classification and staging system in head and neck cancer Head Neck 32 2010 1693 1711
4. J.F. Piccirillo, and A.R. Feinstein Clinical symptoms and comorbidity: significance for the prognostic classification of cancer Cancer 77 1996 834 842
5. R. Kazi, C.M. Nutting, P. Rhys-Evans, and K.J. Harrington Significance and prognostic impact of co-morbidity in head and neck cancer J Cancer Res Ther 5 2009 145 147
6. T. Tanvetyanon, T. Padhya, and J. McCaffrey Prognostic factors for survival after salvage reirradiation of head and neck cancer J Clin Oncol 27 2009 1983 1991
7. O.P. Alho, K. Hannula, and A. Luokkala Differential prognostic impact of comorbidity in head and neck cancer Head Neck 29 2007 913 918
8. C.R. Boje Impact of comorbidity on treatment outcome in head and neck squamous cell carcinoma - a systematic review Radiother Oncol 2013
9. Y. Ramakrishnan, V. Paleri, and R. Shah Comorbidity in nasopharyngeal carcinoma: a preliminary communication on the prevalence, descriptive distribution and impact on outcome Clin Otolaryngol 32 2007 484 488
10. S.B. Edge, and C.C. Compton The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM Ann Surg Oncol 17 2010 1471 1474
11. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
12. R.A. Deyo, D.C. Cherkin, and M.A. Ciol Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 1992 613 619
13. V. Paleri, and R.G. Wight A cross-comparison of retrospective notes extraction and combined notes extraction and patient interview in the completion of a comorbidity index (ACE-27) in a cohort of United Kingdom patients with head and neck cancer J Laryngol Otol 116 2002 937 941
14. V. Paleri, and R.G. Wight Applicability of the adult comorbidity evaluation - 27 and the Charlson indexes to assess comorbidity by notes extraction in a cohort of United Kingdom patients with head and neck cancer: a retrospective study J Laryngol Otol 116 2002 200 205
15. B. Singh, M. Bhaya, and M. Zimbler Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma Head Neck 20 1998 1 7
16. J.F. Piccirillo, R.M. Tierney, and I. Costas Prognostic importance of comorbidity in a hospital-based cancer registry JAMA 291 2004 2441 2447
17. C. Zhao, and F.Lu.L.X. Han Ai Zheng 23 2004 1532 1537
18. W.F. Li, Y. Sun, and M. Chen Locoregional extension patterns of nasopharyngeal carcinoma and suggestions for clinical target volume delineation Chin J Cancer 31 2012 579 587
19. S.B. Liang, Y. Sun, and L.Z. Liu Extension of local disease in nasopharyngeal carcinoma detected by magnetic resonance imaging: improvement of clinical target volume delineation Int J Radiat Oncol Biol Phys 75 2009 742 750
20. H.I. Yang, M.F. Yuen, and H.L. Chan Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score Lancet Oncol 12 2011 568 574
21. C.T. Liu, T.J. Chiu, and T.L. Huang Impact of comorbidity on survival for locally advanced head and neck cancer patients treated by radiotherapy or radiotherapy plus chemotherapy Chang Gung Med J 33 2010 283 291
22. F.R. Datema, M.B. Ferrier, M.P. van der Schroeff, and R.J. Baatenburg de Jong Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients Head Neck 32 2010 728 736
23. C.R. Boje, S.O. Dalton, and T.K. Gronborg The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database Acta Oncol 52 2013 285 293
24. S.F. Hall, P.A. Groome, J. Irish, and B. O'Sullivan Towards further understanding of prognostic factors for head and neck cancer patients: the example of hypopharyngeal cancer Laryngoscope 119 2009 696 702
25. A. Homma, T. Sakashita, and N. Oridate Importance of comorbidity in hypopharyngeal cancer Head Neck 32 2010 148 153
26. H.S. Te, and D.M. Jensen Epidemiology of hepatitis B and C viruses: a global overview Clin Liver Dis 14 2010 1 21 vii
27. J.F. Piccirillo, A. Vlahiotis, and L.B. Barrett The changing prevalence of comorbidity across the age spectrum Crit Rev Oncol Hematol 67 2008 124 132
28. B.C. Reid, A.J. Alberg, and A.C. Klassen Comorbidity and survival of elderly head and neck carcinoma patients Cancer 92 2001 2109 2116
29. A. Sanabria, A.L. Carvalho, and J.G. Vartanian Comorbidity is a prognostic factor in elderly patients with head and neck cancer Ann Surg Oncol 14 2007 1449 1457
30. A.Y. Chen, L.K. Matson, D. Roberts, and H. Goepfert The significance of comorbidity in advanced laryngeal cancer Head Neck 23 2001 566 572
31. J.F. Piccirillo, and A. Vlahiotis Comorbidity in patients with cancer of the head and neck: prevalence and impact on treatment and prognosis Curr Oncol Rep 8 2006 123 129
32. J.F. Piccirillo Importance of comorbidity in head and neck cancer Laryngoscope 110 2000 593 602
33. X. Liu, X. Li, and N. Jiang Prognostic value of chronic hepatitis B virus infection in patients with nasopharyngeal carcinoma: Analysis of 1301 patients from an Endemic Area in China Cancer 2013
34. G. Peng, S. Li, and W. Wu PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients Mol Immunol 45 2008 963 970
35. B. Oliviero, A. Cerino, and S. Varchetta Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections J Hepatol 55 2011 53 60
36. W.L. Read, R.M. Tierney, and N.C. Page Differential prognostic impact of comorbidity J Clin Oncol 22 2004 3099 3103